Benzinga | Jul 27, 2021 04:39PM EDT

Chemed Q2 Adj. EPS $4.60 Beats $4.29 Estimate, Sales $532.00M Beat $511.85M Estimate; Raises FY21 Guidance

Chemed (NYSE:CHE) reported quarterly earnings of $4.60 per share which beat the analyst consensus estimate of $4.29 by 7.23 percent. This is a 4.31 percent increase over earnings of $4.41 per share from the same period last year. The company reported quarterly sales of $532.00 million which beat the analyst consensus estimate of $511.85 million by 3.94 percent. This is a 5.93 percent increase over sales of $502.20 million the same period last year.